Frontiers
US$ 27.45
ghk-cu downregulates il-6 Biological efficacy of after ionic-liquid loading. (a) Cellular GHK-Cu may Prevent Oxidative Stress
Description
Your practitioner will recommend an appropriate treatment schedule for your needs
Clinical trials used doses as high as 1 mg per day without safety concerns, but 300 mcg is the most commonly referenced dose in peptide medicine literature and in the investigational protocols that have been published since the formal trials concluded
The peptide has a short half-life of less than 30 minutes and is rapidly metabolized, which means consistent dosing protocols matter significantly
10.1021/acs.jmedchem.7b01422 8 BachD.-H.KimD.BaeS
